Welcome to our dedicated page for ARDELYX SEC filings (Ticker: ARDX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ARDELYX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ARDELYX's regulatory disclosures and financial reporting.
ARDELYX, INC. officer John E. Bishop reported a small sale of common stock tied to restricted stock unit (RSU) vesting. He disposed of 2,306 shares at an average price of $6.2675 per share, and held 336,845 shares afterward.
According to the footnote, the transaction was an automatic sell-to-cover required by the original RSU grant terms, with shares sold solely to pay applicable withholding taxes. This indicates a routine, compensation-related tax event rather than a discretionary open-market sale based on a view of the stock.
ARDELYX, INC. reported that Chief Human Resources Officer Brady James Parker had 1,846 shares of common stock sold at an average price of $6.2675 per share. According to the footnote, this automatic sell-to-cover transaction occurred upon RSU vesting to satisfy withholding taxes, leaving him with 261,066 shares directly owned.
ARDELYX, INC. Chief Commercial Officer Eric Duane Foster reported sales of 7,998 shares of common stock on May 21, 2026 at a price of $6.2675 per share.
According to the footnote, these trades were an automatic sell-to-cover tied to vested restricted stock units and were executed solely to cover applicable withholding taxes rather than as discretionary open-market sales.
ARDELYX, INC. Chief Business Officer Mike Kelliher reported selling a total of 7,248 shares of common stock on May 21, 2026 at a price of $6.2675 per share in three separate transactions. A footnote explains these sales were an automatic sell-to-cover triggered by the vesting of restricted stock units, with shares sold solely to cover applicable withholding taxes. This indicates the activity was a tax-related mechanism tied to equity compensation rather than a discretionary reduction of his investment in the company.
Ardelyx, Inc. Chief Patient Officer Laura A. Williams reported multiple open-market sales totaling 6,989 shares of common stock at $6.2675 per share. According to the footnote, these transactions were automatic sell-to-cover trades tied to RSU vesting, executed solely to pay withholding taxes. Williams continued to hold 429,093 shares directly after the transactions.
ARDELYX, INC. President & CEO Michael Raab reported routine sales of company common stock tied to restricted stock unit (RSU) vesting. On May 21, 2026, entities associated with him sold a total of 54,748 shares of Ardelyx common stock at $6.2675 per share.
According to the disclosure, these transactions were an automatic sell-to-cover required by the original RSU grant terms, and the shares were sold solely to cover applicable withholding taxes at vesting. After these sales, Raab directly held about 1,759,848 common shares, with additional indirect holdings of 1,000 shares and 24,364 shares held in family-related trusts.
ARDX submitted a Rule 144 notice relating to Common Stock tied to the vesting of 24,986 restricted stock units on 05/19/2026. The filing also lists three dispositions by Mike Kelliher on 02/20/2026 of 8,434, 1,159 and 2 shares with reported proceeds of $49,465.41, $6,622.29 and $11.41, respectively.
ARDX Form 144 filing records vesting-related sale activity. 5,355 restricted stock units vested on 05/19/2026 and are listed as securities to be sold. The filing also shows prior dispositions on 02/20/2026 of 1,786 shares for $10,474.89 and 247 shares for $1,411.31.
James Parker Brady submitted a Form 144 notice relating to Common Stock of ARDX. The filing lists 6,216 shares to be sold on 05/19/2026 in connection with the vesting of restricted stock units for services rendered. The filing also discloses sales during the past three months: 2,234 shares sold on 02/20/2026 for $13,102.41 and 309 shares sold on 02/20/2026 for $1,765.56.
ARDX filed a Form 144 reporting a proposed sale of Common Stock and vesting of restricted stock units. The filing lists 28,415 shares tied to vesting on 05/19/2026. It also discloses recent dispositions by Eric Duane Foster on 02/20/2026, including 9,176 and 1,261 shares.